T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ameriprise Financial
AMP
$49.8B
| $1.38B | 0.29% |
15,325,030
+138,374
| +0.9% | +$13.4M |
|
|
RDS.A
77
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.37B | 0.29% |
26,138,317
-819,946
| -3% | -$39.5M |
|
78
Vulcan Materials
VMC
$37.3B
| $1.36B | 0.29% |
11,313,868
-1,632,500
| -13% | -$185M |
|
|
MBLY
79
DELISTED
Mobileye N.V.
MBLY
| $1.36B | 0.29% |
29,410,483
+437,725
| +2% | +$16.8M |
|
80
Johnson Controls International
JCI
$93.7B
| $1.35B | 0.29% |
29,161,334
-331,428
| -1% | -$14.6M |
|
81
Textron
TXT
$15.2B
| $1.35B | 0.29% |
36,918,587
+2,782,844
| +8% | +$106M |
|
82
Wells Fargo
WFC
$264B
| $1.35B | 0.29% |
28,451,590
-4,401,300
| -13% | -$215M |
|
83
Exelon
EXC
$46.2B
| $1.34B | 0.28% |
51,603,191
+9,561,162
| +23% | +$237M |
|
84
FedEx
FDX
$76.1B
| $1.33B | 0.28% |
8,762,741
+621,633
| +8% | +$101M |
|
|
85
Liberty Global Class C
LBTYK
$3.4B
| $1.28B | 0.27% |
44,718,415
+23,848,697
| +114% | +$752M |
|
86
Crown Castle
CCI
$31.4B
| $1.27B | 0.27% |
12,496,177
+855,506
| +7% | +$77.6M |
|
|
HOLX
87
DELISTED
Hologic
HOLX
| $1.27B | 0.27% |
36,579,489
+15,159,949
| +71% | +$525M |
|
88
Procter & Gamble
PG
$338B
| $1.26B | 0.27% |
14,901,594
+4,022,284
| +37% | +$330M |
|
89
Ashland
ASH
$3.43B
| $1.26B | 0.27% |
22,447,821
-802,887
| -3% | -$44.4M |
|
90
FirstEnergy
FE
$27.1B
| $1.25B | 0.27% |
35,949,512
-7,956,488
| -18% | -$270M |
|
91
Henry Schein
HSIC
$9.94B
| $1.25B | 0.27% |
18,065,115
+414,173
| +2% | +$28M |
|
92
Texas Instruments
TXN
$257B
| $1.25B | 0.26% |
19,874,872
+1,274,930
| +7% | +$75.8M |
|
93
Alibaba
BABA
$307B
| $1.23B | 0.26% |
15,427,790
-2,381,322
| -13% | -$186M |
|
94
PayPal
PYPL
$50.5B
| $1.22B | 0.26% |
33,355,075
+5,387,307
| +19% | +$206M |
|
95
EQT Corp
EQT
$34B
| $1.22B | 0.26% |
28,880,634
+6,795,542
| +31% | +$264M |
|
96
Home Depot
HD
$353B
| $1.22B | 0.26% |
9,531,009
-378,817
| -4% | -$50.1M |
|
97
Canadian Natural Resources
CNQ
$98.3B
| $1.19B | 0.25% |
79,009,156
-17,860,462
| -18% | -$252M |
|
98
Walt Disney
DIS
$178B
| $1.19B | 0.25% |
12,184,731
-2,805,954
| -19% | -$281M |
|
|
RHT
99
DELISTED
Red Hat Inc
RHT
| $1.18B | 0.25% |
16,290,259
+765,107
| +5% | +$57.3M |
|
100
Mattel
MAT
$4.3B
| $1.18B | 0.25% |
37,680,206
-1,868,817
| -5% | -$59.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.